Biotech Stock Roundup: BIIB’s Acquisition, PTCT, LRMR Gain on Updates & More News
ZacksBiogen (BIIB) and PTC Therapeutics, Inc. (PTCT) are in the spotlight following acquisition news and regulatory updates, respectively.
Biogen (BIIB) and PTC Therapeutics, Inc. (PTCT) are in the spotlight following acquisition news and regulatory updates, respectively.